13FCRINETICS PHARMACEUTICALS IN (CRNXGBP)
3 tracked managers currently hold CRNXGBP on their latest filing. Change is versus that manager’s previous filing. Reported as of quarter end, filed up to ~45 days later, not live positions.
Sort: Size Weight change
Sorted by reported value on the latest filing.
| Manager | Period | Change | Value | Weight | Prev weight | Shares | Δ shares |
|---|---|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | Q2 2026 | TRIM | $5.2M | 0.0 % | 0.0 % | 138,329 | -179,605 |
| TWO SIGMA INVESTMENTS, LP | Q2 2026 | HELD | $3.3M | 0.0 % | 0.0 % | 87,299 | 0 |
| Point72 Asset Management, L.P. | Q2 2026 | NEW | $1.7M | 0.0 % | — | 46,381 | NEW |